GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2l1 | decreases expression | EXP | | 6480464 | CTD | sodium arsenite results in decreased expression of BCL2L1 protein | PMID:19616567 | Bcl2l1 | increases expression | EXP | | 6480464 | CTD | sodium arsenite results in increased expression of BCL2L1 protein | PMID:20830294 | Bcl2l1 | multiple interactions | EXP | | 6480464 | CTD | Taurine inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein]; Taurine inhibits the reaction [sodium arsenite results in increased expression of BCL2L1 protein alternative form] | PMID:19616567 PMID:20830294 | Bcl2l1 | affects expression | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | sodium arsenite affects the expression of BCL2L1 mRNA | PMID:29319823 | Bcl2l1 | affects localization | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | sodium arsenite affects the localization of BCL2L1 protein | PMID:16166651 | Bcl2l1 | decreases expression | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | sodium arsenite results in decreased expression of BCL2L1 mRNA | PMID:16014739 | Bcl2l1 | decreases expression | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | sodium arsenite results in decreased expression of BCL2L1 mRNA; sodium arsenite results in decreased expression of BCL2L1 protein | PMID:12760830 PMID:26404762 PMID:28586017 PMID:31139082 | Bcl2l1 | increases expression | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | sodium arsenite results in increased expression of BCL2L1 mRNA | PMID:17451858 | Bcl2l1 | increases expression | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | sodium arsenite results in increased expression of BCL2L1 mRNA; sodium arsenite results in increased expression of BCL2L1 protein | PMID:24431212 PMID:24570342 | Bcl2l1 | multiple interactions | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of BCL2L1 protein; [sodium arsenite results in increased abundance of Arsenic] promotes the reaction [ATF3 protein binds to BCL2L1 promoter]; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2L1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2L1 protein; ATF3 protein affects the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2L1 mRNA]; ATF3 protein affects the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2L1 protein]; LCN2 mutant form inhibits the reaction [sodium arsenite results in increased expression of BCL2L1 mRNA]; pterostilbene inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein]; sodium arsenite promotes the reaction [BBC3 protein binds to BCL2L1 protein]; tetramethylpyrazine inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein] | PMID:24570342 PMID:26404762 PMID:31139082 PMID:32802178 PMID:33921748 PMID:34798143 | |
Go Back to source page | Continue to Ontology report |